These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8389848)

  • 1. A preliminary study of in vitro antibiotic activity of saperconazole and other azoles on Paracoccidioides brasiliensis.
    San-Blas G; Calcagno AM; San-Blas F
    J Med Vet Mycol; 1993; 31(2):169-74. PubMed ID: 8389848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
    Rodero L; Canteros CE; Rivas C; Lee W; Davel G
    Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of Paracoccidioides brasiliensis yeast form to antifungal drugs.
    Hahn RC; Hamdan JS
    Mycoses; 2000; 43(11-12):403-7. PubMed ID: 11204357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
    Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
    Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of saperconazole (R 66 905) in vitro.
    Odds FC
    J Antimicrob Chemother; 1989 Oct; 24(4):533-7. PubMed ID: 2613602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
    Hahn RC; Hamdan JS
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1997-2000. PubMed ID: 10858371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species.
    Denning DW; Hanson LH; Stevens DA
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):693-7. PubMed ID: 2171940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):572-4. PubMed ID: 2166936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole.
    Cardona-Castro N; Agudelo-Flórez P; Restrepo-Molina R
    Mem Inst Oswaldo Cruz; 1996; 91(6):779-84. PubMed ID: 9283666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole.
    Meerpoel L; Heeres J; Backx LJ; Van der Veken LJ; Hendrickx R; Corens D; De Groot A; Leurs S; Van der Eycken L; Weerts J; Luyts P; Van Gerven F; Woestenborghs FA; Van Breda A; Oris M; van Dorsselaer P; Willemsens GH; Bellens D; Marichal PJ; Vanden Bossche HF; Odds FC
    ChemMedChem; 2010 May; 5(5):757-69. PubMed ID: 20379992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degenerative changes in fungi after itraconazole treatment.
    Borgers M; Van de Ven MA
    Rev Infect Dis; 1987; 9 Suppl 1():S33-42. PubMed ID: 3027844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Denning DW; Hanson LH; Perlman AM; Stevens DA
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
    Ballard SA; Ellis SW; Kelly SL; Troke PF
    J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of papulacandin B on glucan synthesis in Paracoccidioides brasiliensis.
    Dávila T; San-Blas G; San-Blas F
    J Med Vet Mycol; 1986 Jun; 24(3):193-202. PubMed ID: 3735029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of R126638 and ketoconazole against Malassezia species.
    Faergemann J; Ausma J; Borgers M
    Acta Derm Venereol; 2006; 86(4):312-5. PubMed ID: 16874415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.